Ajanta Pharma has launched Memantine Hydrochloride Tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA Inc. Memantine Hydrochloride is an anti-dementia drug and is a bioequivalent generic version of Namenda. The company has launched it in 2 strengths 5mg & 10mg tablets to address different levels of treatment.
Memantine Hydrochloride Tablets is part of an ever-growing portfolio of products that Ajanta has developed for the US market. Till date, the United States Food & Drug Administration (USFDA) has granted 10 final approvals and 2 tentative approvals to Ajanta Pharma for its Abbreviated New Drug Application (ANDA). Additional 14 ANDAs are pending approval from the USFDA.
Ajanta Pharma is a specialty pharmaceutical formulation company with global headquarters in Mumbai, India. Over 6,000 employees are engaged in developing, manufacturing and marketing of quality finished dosages across 30+ countries.
